Find, compare & contact
Palivizumab API Manufacturers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Palivizumab API 188039-54-5?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Palivizumab. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Palivizumab
- Synonyms:
- anti-RSV , Synagis
- Cas Number:
- 188039-54-5
- DrugBank number:
- DB00110
- Unique Ingredient Identifier:
- DQ448MW7KS
About Palivizumab
Here is a short description about Palivizumab. Humanized monoclonal antibody (IgG1k) produced by recombinant DNA technology, directed to an epitope in the A antigenic site of the F protein of respiratory syncytial virus (RSV). Synagis is a composite of human (95%) and murine (5%) antibody sequences. The human heavy chain sequence was derived from the constant domains of human IgG1 and the variable framework regions of the VH genes Cor (1) and Cess (2).
The human lightchain sequence was derived from the constant domain of Ck and the variable framework regions of the VL gene K104 withJk-4. Palivizumab is expressed from a stable murine (mouse) myeloma cell line (NS0). Palivizumab is composed of to heavy chains (50. kDa each) and two light chains (27. kDa each), contains 1-2% carbohydrate by weight and has a molecular weight of 147. kDa +/- 1 kDa (MALDI-TOF).
Not sure if this is the exact product you're looking for? Contact the supplier by using the send inquiry button.
